SCHEMBL805591

SCHEMBL805591

Cc1ccccc1-c1nc(C)c(C)c(C)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.49
CYP1A2 P05177 8/20 0.47
CYP3A4 P08684 6/20 0.47
CYP2D6 P10635 5/20 0.47
CLK4 Q9HAZ1 5/20 0.47
CYP2C19 P33261 4/20 0.47
HSD17B10 Q99714 4/20 0.47
MAPK1 P28482 3/20 0.47
TSHR P16473 3/20 0.47
ALOX15 P16050 2/20 0.47
USP2 O75604 1/20 0.47
GAA P10253 3/20 0.47
NPC1 O15118 8/20 0.44
SMN1; SMN2 Q16637 7/20 0.44
RAB9A P51151 7/20 0.44
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
PKM P14618 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11810775 0.85 HSP90AA1 (0.55) HSP90AA1CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL18216913 0.79 L3MBTL1 (0.54) HSP90AA1CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL14164034 0.78 ALDH1A1 (0.49) HSP90AA1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL12697515 0.76 CYP1A2 (0.49) HSP90AA1CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL17993428 0.76 L3MBTL1 (0.61) HSP90AA1CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL6172768 0.76 CYP1A2 (0.49) HSP90AA1CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL3894503 0.76 HSP90AA1 (0.71) HSP90AA1CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL18939743 0.75 GAA (0.59) HSP90AA1CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL11286099 0.74 KMT2A (0.56) HSP90AA1CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL10646087 0.74 HSP90AA1 (0.46) HSP90AA1CYP1A2CYP3A4CYP2D6CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120071657-A1 TRIAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-03-22 US disclosed
US-7691853-B2 Pyrazole compounds useful as protein kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071657-A1 TRIAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS GSK3B, GSK3A, CDK19 HSP90AA1 4129/4885CYP1A2 3042/4885CYP3A4 2929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.